SOCMA: Society of Chemical Manufacturers and Affiliates

09/08/10
SOCMA Welcomes President’s Call to Permanently Extend R&D Tax Credit

Washington, DC – The Society of Chemical Manufacturers and Affiliates (SOCMA) today welcomed President Barack Obama’s proposal to Congress to increase and permanently extend the research and development (R&D) tax credits for US businesses. The extension, estimated at $100 billion over 10 years, will assist with job growth within the chemical manufacturing sector.

08/25/10
SOCMA: Regulatory Inconsistencies in EPA's Boiler MACT Proposal Create Uncertainties

Washington, DC – In comments submitted August 23, 2010 to the U.S. Environmental Protection Agency (EPA), the Society of Chemical Manufacturers and Affiliates (SOCMA) voiced strong concerns regarding the Agency’s proposed National Emission Standards for Hazardous Air Pollutants for Major Sources: Industrial, Commercial, and Institutional Boilers.

08/11/10
SOCMA Commends Signing of Duty Suspension Bill

Washington, DC – The Society of Chemical Manufacturers and Affiliates (SOCMA) commended today’s signing by President Obama of H.R. 4380, the “United States Manufacturing Enhancement Act of 2010,” also known commonly as the Miscellaneous Tariff Bill (MTB). The bill, which is a compilation of duty suspensions, allows manufacturers to cut production costs by eliminating the duty for certain raw materials imported to the U.S.

08/04/10
SOCMA’s Bulk Pharmaceuticals Task Force Supports Senate Drug Safety Bill

Washington, DC – The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today announced its support for a new drug safety bill that would give the Food and Drug Administration (FDA) greater authority to protect the US drug supply.

07/29/10
SOCMA Tells Congress TSCA Reform Bill Creates Major Challenges for Industry, EPA

Washington, DC – The Society of Chemical Manufacturers and Affiliates today told Congress that recently-introduced legislation to reform US chemical safety laws is overreaching and unworkable, saying it would have a substantially negative impact on an industry already fighting recession and foreign competition.

07/28/10
Key Senate Panel Approves 3-Year Extension of Chemical Security Rules

Washington, DC – Legislation that would make existing chemical security standards permanent took a major step forward today, winning bipartisan support in the Senate Homeland Security and Government Affairs Committee. Following a markup, lawmakers voted unanimously to approve an amendment from Senator Susan Collins (R-ME) to the Chemical Facility Anti-Terrorism Act of 2009 (H.R. 2868).

07/23/10
New TSCA Reform Bill Threatens Domestic Chemical Manufacturing and Innovation

Washington, DC – Legislation that would significantly hamper innovation and impose stringent regulatory burdens on batch, specialty and custom chemical manufacturers – particularly small and mid-sized companies – was introduced last night in the House of Representatives by Congressmen Bobby L. Rush (D-IL) and Henry Waxman (D-CA), who both serve on the influential House Energy Commerce Committee.

07/21/10
SOCMA Welcomes House Passage of Miscellaneous Tariff Bill

Washington, DC –The Society of Chemical Manufacturers and Affiliates (SOCMA) today commended the House of Representatives for helping create and preserve thousands of US chemical manufacturing jobs by passing the Miscellaneous Tariff Bill (MTB), a key legislative priority for SOCMA and its members.

07/15/10
SOCMA Responds to the “Secure Chemical Facilities Act”

Washington, DC – The Society of Chemical Manufacturers and Affiliates (SOCMA) today expressed strong concern over legislation introduced in the US Senate, mandating that chemical facilities switch to so-called safer chemicals or processes in a misguided attempt to safeguard such critical infrastructure from a terrorist incident.

07/06/10
SOCMA’s Bulk Pharmaceuticals Task Force Develops API Quality Agreement for Custom Manufacturers

Washington, DC –  Just two months after unveiling a standardized quality drug agreement for general manufacturers of active pharmaceutical ingredients (API), SOCMA’s Bulk Pharmaceuticals Task Force (BPTF) today announced it has developed a second template for Custom Manufacturers Organizations (CMOs) and their customers.

      next ›››